As a result, we demonstrated that IL-18BP expression was increased in the lung tissue and serum of IPF patients and that the serum IL-18BP level was an independent prognostic predictor for IPF patients. The gene discussed is IL18BP; the disease is idiopathic pulmonary fibrosis.